Literature DB >> 22990808

Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database.

K Ito1, M M Hutmacher, B W Corrigan.   

Abstract

An assessment of abilities to function independently in daily life is an important clinical endpoint for all Alzheimer's disease (AD) patients and caregivers. A mathematical model was developed to describe the natural history of change of the Functional Assessment Questionnaire (FAQ) from data obtained in normal elderly, mild cognitive impairment, and mild AD in the AD neuroimaging initiative (ADNI) study. FAQ is a bounded outcome (ranging from 0 to 30), with 0 scored as "no impairment" and 30 as "severely impaired". Since many normal elderly patients had 0 scores and some AD patients had scores of 30 in the ADNI database, a censored approach for handling the boundary data was compared with a standard approach, which ignores the bounded nature of the data. Baseline severity, ApoE4 genotype, age, sex, and imaging biomarkers were tested as covariates. The censored approach greatly improved the predictability of the disease progression in FAQ scores. The basic method for handling boundary data used in this analysis is also applicable to handle boundary observations for numerous other endpoints.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990808     DOI: 10.1007/s10928-012-9271-3

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  22 in total

1.  Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

Authors:  Jae Eun Ahn; Mats O Karlsson; Adrian Dunne; Thomas M Ludden
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-08-07       Impact factor: 2.745

2.  An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.

Authors:  Mahesh N Samtani; Michael Farnum; Victor Lobanov; Eric Yang; Nandini Raghavan; Allitia Dibernardo; Vaibhav Narayan
Journal:  J Clin Pharmacol       Date:  2011-06-09       Impact factor: 3.126

3.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

4.  Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.

Authors:  Steve Balsis; Alexis A Unger; Jared F Benge; Lisa Geraci; Rachelle S Doody
Journal:  Alzheimers Dement       Date:  2012-03-30       Impact factor: 21.566

5.  Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.

Authors:  Sid E O'Bryant; Laura H Lacritz; James Hall; Stephen C Waring; Wenyaw Chan; Zeina G Khodr; Paul J Massman; Valerie Hobson; C Munro Cullum
Journal:  Arch Neurol       Date:  2010-06

Review 6.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

7.  Disease system analysis: basic disease progression models in degenerative disease.

Authors:  Teun M Post; Jan I Freijer; Joost DeJongh; Meindert Danhof
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

8.  Disease progression meta-analysis model in Alzheimer's disease.

Authors:  Kaori Ito; Sima Ahadieh; Brian Corrigan; Jonathan French; Terence Fullerton; Thomas Tensfeldt
Journal:  Alzheimers Dement       Date:  2009-07-09       Impact factor: 21.566

9.  Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

Authors:  N H Holford; K E Peace
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  12 in total

1.  Modeling of bounded outcome scores with data on the boundaries: application to disability assessment for dementia scores in Alzheimer's disease.

Authors:  Xu Steven Xu; Mahesh Samtani; Min Yuan; Partha Nandy
Journal:  AAPS J       Date:  2014-08-28       Impact factor: 4.009

Review 2.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

3.  Frequency and impact of informant replacement in Alzheimer disease research.

Authors:  Joshua D Grill; Yan Zhou; Jason Karlawish; David Elashoff
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

4.  The correlation of everyday cognition test scores and the progression of Alzheimer's disease: a data analytics study.

Authors:  Fadi Thabtah; Robinson Spencer; Yongsheng Ye
Journal:  Health Inf Sci Syst       Date:  2020-07-23

5.  Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries.

Authors:  Xu Steven Xu; Mahesh N Samtani; Adrian Dunne; Partha Nandy; An Vermeulen; Filip De Ridder
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-05-05       Impact factor: 2.745

6.  Cognitive/Functional Measures Predict Alzheimer's Disease, Dependent on Hippocampal Volume.

Authors:  Hossein Tabatabaei-Jafari; Marnie E Shaw; Erin Walsh; Nicolas Cherbuin
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

7.  A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers.

Authors:  Zhijun Yao; Bin Hu; Jiaxiang Zheng; Weihao Zheng; Xuejiao Chen; Xiang Gao; Yuanwei Xie; Lei Fang
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

8.  Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Mahesh N Samtani; Nandini Raghavan; Gerald Novak; Partha Nandy; Vaibhav A Narayan
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-24       Impact factor: 2.570

9.  Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials.

Authors:  Steven X Xu; Mahesh N Samtani; Alberto Russu; Omoniyi J Adedokun; Ming Lu; Kaori Ito; Brian Corrigan; Sangeeta Raje; H Robert Brashear; Scot Styren; Chuanpu Hu
Journal:  Alzheimers Dement (N Y)       Date:  2015-07-21

10.  Testing whether the progression of Alzheimer's disease changes with the year of publication, additional design, and geographical area: a modeling analysis of literature aggregate data.

Authors:  Ningyuan Zhang; Xijun Zheng; Hongxia Liu; Qingshan Zheng; Lujin Li
Journal:  Alzheimers Res Ther       Date:  2020-05-26       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.